Lynen L - Search Results

1

HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals.

van Griensven J, Diro E, Lopez-Velez R, Boelaert M, Lynen L, Zijlstra E, Dujardin JC, Hailu A. van Griensven J, et al. Among authors: lynen l. Lancet Infect Dis. 2013 Mar;13(3):251-9. doi: 10.1016/S1473-3099(12)70348-1. Lancet Infect Dis. 2013. PMID: 23427890 Review.

2

Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis.

Boelaert M, Lynen L, Desjeux P, Van der Stuyft P. Boelaert M, et al. Among authors: lynen l. Bull World Health Organ. 1999;77(8):667-74. Bull World Health Organ. 1999. PMID: 10516788 Free PMC article.

3

Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead.

van Griensven J, Lynen L, Colebunders R. van Griensven J, et al. Among authors: lynen l. AIDS. 2009 May 15;23(8):1027. doi: 10.1097/QAD.0b013e328329d04b. AIDS. 2009. PMID: 19414993 No abstract available.

4

An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia.

Lynen L, An S, Koole O, Thai S, Ros S, De Munter P, Sculier D, Arnould L, Fransen K, Menten J, Boelaert M, Van den Ende J, Colebunders R. Lynen L, et al. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):40-8. doi: 10.1097/QAI.0b013e3181af6705. J Acquir Immune Defic Syndr. 2009. PMID: 19550349

5

Substituting nevirapine for efavirenz: risk factors for toxicity in nonnaive patients in a resource-constrained setting.

van Griensven J, Un P, Phe T, Thai S, Lynen L. van Griensven J, et al. Among authors: lynen l. AIDS. 2009 Nov 13;23(17):2374-6. doi: 10.1097/QAD.0b013e328331900c. AIDS. 2009. PMID: 19865033 No abstract available.

6

Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings.

Lynen L, Van Griensven J, Elliott J. Lynen L, et al. Curr Opin HIV AIDS. 2010 Jan;5(1):1-5. doi: 10.1097/COH.0b013e3283333762. Curr Opin HIV AIDS. 2010. PMID: 20046141 Review.

7

Treating HIV infection with drugs for HSV-2 infection?

Buvé A, Lynen L. Buvé A, et al. Among authors: lynen l. Lancet. 2010 Mar 6;375(9717):782-4. doi: 10.1016/S0140-6736(10)60097-9. Epub 2010 Feb 12. Lancet. 2010. PMID: 20153889 No abstract available.

8

Combination therapy for visceral leishmaniasis.

van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. van Griensven J, et al. Among authors: lynen l. Lancet Infect Dis. 2010 Mar;10(3):184-94. doi: 10.1016/S1473-3099(10)70011-6. Lancet Infect Dis. 2010. PMID: 20185097 Review.

9

Challenges in HIV and visceral Leishmania co-infection: future research directions.

Ejara ED, Lynen L, Boelaert M, Van Griensven J. Ejara ED, et al. Among authors: lynen l. Trop Med Int Health. 2010 Oct;15(10):1266-7. doi: 10.1111/j.1365-3156.2010.02612.x. Epub 2010 Aug 17. Trop Med Int Health. 2010. PMID: 20723183 Free article. No abstract available.

10

Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: do we care?

van Griensven J, Sopheak T, Aseffa Y, Van Damme W, Lynen L. van Griensven J, et al. Among authors: lynen l. Trans R Soc Trop Med Hyg. 2010 Oct;104(10):690-2; author reply 692-3. doi: 10.1016/j.trstmh.2010.07.006. Epub 2010 Aug 30. Trans R Soc Trop Med Hyg. 2010. PMID: 20800253 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters